In vitro post-antibiotic effect of fluoroquinolones, macrolides, β-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 4, 2004, Pages 609-615

  Athamna, A ^a,b   Athamna, M ^a   Medlej, B ^a,b   Bast, D J ^c   Rubinstein, E ^b  

^a The Triangle Research/Devmt Center   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Anthrax; PAE; Susceptibility

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GARENOXACIN; LEVOFLOXACIN; LINEZOLID; MACROLIDE; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TELITHROMYCIN; TETRACYCLINE; VANCOMYCIN;

ARTICLE; BACILLUS ANTHRACIS; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL STRAIN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG CLASSIFICATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTANTIBIOTIC EFFECT;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BACILLUS ANTHRACIS; BETA-LACTAMS; CHLORAMPHENICOL; CLINDAMYCIN; FLUOROQUINOLONES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; RIFAMPIN; TETRACYCLINES; VANCOMYCIN; VIRGINIAMYCIN;

EID: 16544379215     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh130     Document Type: Article

References (23)

1. Bigger, J. W. (1944). The bactericidal action of penicillin on Streptococcus pyogenes. Journal of Medical Science 227, 553-68.
2. Eagle, H. & Musselman, A. D. (1949). The slow recovery of bacteria from the toxic effect of penicillin. Journal of Bacteriology 58, 475-90.
3. Gengo, F. M., Mannion, T. W., Nightingale, C. H. et al. (1984). Integration of pharmacokinetics and pharmacodynamics of methicillin in curative treatment of experimental endocarditis. Journal of Antimicrobial Chemotherapy 14, 619-31.
4. Parker, R. F. & Marsh, H. C. (1946). The action of penicillin on Staphylococcus. Journal of Bacteriology 51, 181-6.
5. Bustamante, C. I., Drusano, G. L., Tatem, B. A. et al. (1984). Postantibiotic effect of imipenem on Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 5, 678-82.
6. Craig, W. A. & Gudmundsson, S. (1999). The postantibiotic effect. In Antibiotics in Laboratoty Medicine, 3rd edn (Lorian, V., Ed.), pp. 403-31. Williams & Wilkins, Baltimore, MD, USA.
7. Cozens, R. M., Tuomanen, E., Tosch, W. et al. (1986). Evaluation of the bactericidal activity of β-lactam antibiotics on slowly growing bacteria cultured in the chemostat. Antimicrobial Agents and Chemotherapy 29, 797-802.
8. Eagle, H. (1952). Experimental approach to the problem of treatment failure with penicillin. American Journal of Medicine 13, 389-99.
9. ter Braak, E. W., de Vries, P. J., Bouter, K. P. et al. (1990). Once-daily dosing regimen for aminoglycoside plus β-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone. American Journal of Medicine 89, 58-66.
10. Gilbert, D. N. (1991). Once-daily aminoglycoside therapy. Antimicrobial Agents and Chemotherapy 35, 399-405.
11. Inglesby, T. V., O'Toole, T., Henderson, D. A. et al. (2002). Anthrax as a biological weapon, 2002: updated recommendations for management. Journal of the American Medical Association 287, 2236-52.
12. Mohammed, M. J., Marston, C. K., Popovic, T. et al. (2002). Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods. Journal of Clinical Microbiology 40, 1902-7.
13. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition: Approved Standard M7-A4. NCCLS, Wayne, PA, USA.
14. Athamna, A., Massalha, M., Athamna, M. et al. (2004). In vitro susceptibility of Bacillus anthracis to various antibacterial agents and their time-kill activity. Journal of Antimicrobial Chemotherapy 53, 247-51.
15. Odenholt, I. (2001). Pharmacodynamic effects of subinhibitory antibiotic concentrations. International Journal of Antimicrobial Agents 17, 1-8.
16. Spangler, S. K., Lin, G., Jacobs, M. R. et al. (1998). Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. Antimicrobial Agents and Chemotherapy 42, 1253-5.
17. Licata, L., Smith, C. E., Goldschmidt, R. M. et al. (1997). Comparison of the postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 41, 950-5.
18. Pankuch, G. A., Jacobs, M. R. & Appelbaum, P. C. (1998). Postantibiotic effect of trovafloxacin against Gram-positive and -negative organisms. Antimicrobial Agents and Chemotherapy 42, 1503-5.
19. Odenholt-Tornqvist, I., Löwdin, E. & Cars, O. (1995). Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens. Antimicrobial Agents and Chemotherapy 39, 221-6.
20. Odenholt-Tornqvist, I., Löwdin, E. & Cars, O. (1998). In vitro pharmacodynamic studies of L-749,345 in comparison with imipenem and ceftriaxone against Gram-positive and Gram-negative bacteria. Antimicrobial Agents and Chemotherapy 42, 2365-70.
21. Löwdin, E., Odenholt, I. & Cars, O. (1998). In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy 42, 2739-44.
22. Pankuch, G. A., Jacobs, M. R. & Appelbaum, P. C. (1998). Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against Gram-positive and -negative organisms. Antimicrobial Agents and Chemotherapy 42, 3028-31.
23. Kardas, P. (2002). Patient compliance with antibiotic treatment for respiratory tract infections. Journal of Antimicrobial Chemotherapy 49, 897-903.